Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Dec. 18, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings in Brief: Dec. 18, 2013

Andromeda Biotech, Banner Pharmacaps, Bayer Healthcare, Genmab, Gilead, GlaxoSmithKline, Ipsen, Lonza, Mylan, Octapharma, Omeros, Regeneron, Versartis

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II
Octapharma begins enrolling MS patients . . . read more

Phase III
Andromeda begins dosing in diabetes extension trial . . . read more

Gilead posts SOF/LDV SVR12 results . . . read more

Filings
Eylea sBLA accepted by FDA . . . read more

GSK, Genmab sBLA for Arzerra in CLL gets priority review . . . read more

Ipsen files to resupply Increlex in EU . . . read more

Mylan, Banner reach Targretin settlement with Eisai, Valeant . . . read more

Omeros receives Orphan Designation for TMA treatment . . . read more

Versartis GHD treatment gets Orphan Designation . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics